Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-310826
Filing Date
2011-11-14
Accepted
2011-11-14 16:01:58
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d223042d10q.htm 10-Q 442150
2 CERTIFICATION d223042dex311.htm EX-31.1 6159
3 CERTIFICATION d223042dex312.htm EX-31.2 6180
4 CERTIFICATION d223042dex321.htm EX-32.1 2859
5 CERTIFICATION d223042dex322.htm EX-32.2 2890
  Complete submission text file 0001193125-11-310826.txt   1970178

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20110930.xml EX-101.INS 282713
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20110930.xsd EX-101.SCH 11616
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20110930_cal.xml EX-101.CAL 31238
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20110930_def.xml EX-101.DEF 10574
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20110930_lab.xml EX-101.LAB 110752
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20110930_pre.xml EX-101.PRE 77196
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 111202299
SIC: 2834 Pharmaceutical Preparations